Lv1
60 积分 2025-07-22 加入
Urticaria in China: incidence, prevalence, and disability-adjusted life years compared with G20 countries: findings from the Global Burden of Disease study 2021
7个月前
已完结
EMPEROR reduced – cardiac and renal targets with empagliflozin in patients with heart failure with reduced ejection fraction
11个月前
已关闭
Renal effects of sodium-glucose co-transporter-2 inhibitors in patients with heart failure with reduced or preserved ejection fraction
11个月前
已关闭
Efficacy of empagliflozin in patients with heart failure according to baseline KDIGO risk categories – findings from the EMPEROR-Pooled
11个月前
已关闭
Renal effects of sodium-glucose co-transporter-2 inhibitors in patients with heart failure with reduced or preserved ejection fraction
11个月前
已关闭
Sodium‐glucose co‐transporter‐2 inhibitors and major adverse limb events: A trial‐level meta‐analysis including 51 713 individuals
11个月前
已完结
The comparison of remimazolam and midazolam in bronchoscopic sedation: a systematic review and meta-analysis of randomized controlled trials
11个月前
已完结
SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials
11个月前
已完结
Efficacy of empagliflozin in patients with heart failure according to baseline KDIGO risk categories – findings from the EMPEROR-Pooled
11个月前
已关闭
EMPEROR-Reduced: Empagliflozin and Outcomes in Heart Failure and CKD
11个月前
已关闭
皖公网安备34019202002308
